Related Experiment Video
Updated: Jan 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy
Kewei Xie1, Chenqi Xu1, Minfang Zhang1
1Department of Nephrology, Molecular Cell Lab for Kidney Disease, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, People's Republic of China.
Abstract:
Podocytes are terminally differentiated cells with little proliferative capacity. The high expression levels of cell cycle inhibitory proteins, including p21, p27, and p57, play an important role in maintaining the low level of proliferation of mature podocytes. In the present study, we aimed to explore the role of yes-associated protein (YAP) signalling in adriamycin-induced podocyte re-entry into the cell cycle and dedifferentiation. Proliferating cell nuclear antigen (PCNA)-, cyclin-dependent kinase 4 (CDK4)-, and Cyclin D1-positive podocytes were found in mice with adriamycin-induced nephropathy. In vitro, adriamycin administration increased the percentage of cells in S phase and the upregulation of mesenchymal-related marker proteins. CDK4 and cyclin D1 were significantly up-regulated after incubation with adriamycin. Overexpression of YAP in podocytes promoted their entry into the cell cycle; up-regulated cyclin D1, desmin, and snail2 expression and down-regulated Wilms' tumour 1 (WT1) and nephrin production. Recombinant murine FGF-basic induced podocytes to re-enter the cell cycle, inhibited WT1 and nephrin, and increased desmin and snail2 expression. Pretreating podocytes with verteporfin, an inhibitor of YAP/ TEA domain transcription factor (TEAD), decreased the adriamycin-induced overexpression of cyclin D1 and reduced the ratio of S-phase podocytes. This result was further verified by knocking down YAP expression using RNA interference. In conclusion, adriamycin induced podocytes to re-enter the cell cycle via upregulation of CDK4 and cyclin D1 expression, which was at least partly mediated by YAP signalling. Re-entry into the cell cycle induced the over-expression of mesenchymal markers in podocytes.
Insights
Adriamycin causes podocytes to re-enter the cell cycle and dedifferentiate by upregulating CDK4 and cyclin D1, a process mediated by yes-associated protein (YAP) signaling. This leads to the overexpression of mesenchymal markers in kidney cells.
Area of Science:
- Nephrology
- Cell Biology
- Molecular Biology
Background:
- Podocytes are terminally differentiated kidney cells with limited proliferation capacity, maintained by cell cycle inhibitors like p21, p27, and p57.
- Adriamycin-induced nephropathy is characterized by podocyte injury and potential dedifferentiation.
Purpose of the Study:
- To investigate the role of yes-associated protein (YAP) signaling in adriamycin-induced podocyte cell cycle re-entry and dedifferentiation.
- To elucidate the molecular mechanisms underlying adriamycin's effects on podocytes.
Main Methods:
- In vivo studies using mice with adriamycin-induced nephropathy.
- In vitro experiments involving adriamycin treatment of cultured podocytes.
- Analysis of cell cycle markers (PCNA, CDK4, Cyclin D1), mesenchymal markers (desmin, snail2), and podocyte-specific markers (WT1, nephrin).
- Manipulation of YAP signaling using overexpression, RNA interference, and the YAP/TEAD inhibitor verteporfin.
Main Results:
- Adriamycin induced podocyte proliferation (PCNA+, S-phase increase) and dedifferentiation in vivo and in vitro, with upregulation of CDK4 and Cyclin D1.
- Overexpression of YAP promoted cell cycle entry, upregulated mesenchymal markers, and downregulated podocyte markers.
- FGF-basic mimicked adriamycin's effects on cell cycle and marker expression.
- Inhibition of YAP/TEAD signaling with verteporfin or YAP knockdown reduced adriamycin-induced cell cycle re-entry and Cyclin D1 overexpression.
Conclusions:
- Adriamycin induces podocyte cell cycle re-entry and dedifferentiation, at least partly through YAP signaling, leading to CDK4 and Cyclin D1 upregulation.
- YAP signaling plays a crucial role in mediating adriamycin's detrimental effects on podocytes, promoting a mesenchymal phenotype.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Anaphase Promoting Complex
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...

